TET3 Protein Represses Proliferation of the MG-63 Human Osteosarcoma Cell Line by Regulating DNA Demethylation: an Epigenetic Study
Folia Biologica · 2024
DOI: 10.14712/fb2024070020113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Biologica, 2024. Verfasst von Shijun Hang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Haian Hospital of Traditional Chinese Medicine, Haian, China. Hauptthemen laut MEDLINE: 5-Methylcytosine, Cell Proliferation, Dioxygenases, DNA Demethylation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wuxi Municipal Bureau on Science and Technology, Jiangsu Provincial Commission of Health and Family Planning.
Abstract (Originalsprache)
Recent studies have highlighted the significant role of 5-hydroxymethylcytosine (5hmC) in carcinogenesis. However, the specific role of 5hmC in osteosarcoma (OS) remains largely unexplored. Therefore, this study aimed to investigate the function of 5hmC and TET3 in OS. In this study, we found a decreased total level of 5hmC in OS tissues. The expression of the TET3 protein was also decreased in OS. Importantly, the decreased levels of TET3 were associated with a decreased disease-free survival (DFS) rate in patients. To investigate the role of TET3 and 5hmC in OS, we manipulated the levels of TET3 in MG-63 cells. Silencing TET3 in these cells resulted in a twofold increase in proliferation. Additionally, the level of 5hmC decreased in these cells. Conversely, over-expression of TET3 in MG-63 cells led to the expected inhibition of proliferation and invasion, accompanied by an increase in 5hmC levels. In conclusion, both 5hmC and TET3 protein levels were decreased in OS. Additionally, the over-expression of TET3 inhibited the proliferation of MG-63 cells, while the suppression of TET3 had the opposite effect. These findings suggest that decreased levels of 5hmC and TET3 may serve as potential markers for OS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Haian Hospital of Traditional Chinese Medicine, Haian, China.
- Medical College of Yangzhou University, China.
- Department of Emergency, Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an), China.
- Department of Orthopedics, Haian Hospital of Traditional Chinese Medicine, Haian, China. 13301478499@163.com.
- Medical College of Yangzhou University, China. 13301478499@163.com.
- Department of Orthopedics, The Fourth Hospital of Wuhan, Wuhan, China.
Förderung
- Wuxi Municipal Bureau on Science and Technology
- Jiangsu Provincial Commission of Health and Family Planning
Zitieren
APA
Hang, S., Cui, B., Wei, A., Li, Z., & Sun, H. (2024). TET3 Protein Represses Proliferation of the MG-63 Human Osteosarcoma Cell Line by Regulating DNA Demethylation: an Epigenetic Study. Folia Biologica. https://doi.org/10.14712/fb2024070020113
Vancouver
Hang S, Cui B, Wei A, Li Z, Sun H. TET3 Protein Represses Proliferation of the MG-63 Human Osteosarcoma Cell Line by Regulating DNA Demethylation: an Epigenetic Study. Folia Biologica. 2024. doi:10.14712/fb2024070020113
BibTeX
@article{Hang2024,
author = {Hang, Shijun and Cui, Bingjun and Wei, Aichun and Li, Zi and Sun, Haitao},
title = {TET3 Protein Represses Proliferation of the MG-63 Human Osteosarcoma Cell Line by Regulating DNA Demethylation: an Epigenetic Study},
journal = {Folia Biologica},
year = {2024},
doi = {10.14712/fb2024070020113}
}
EUVIMED